Global Organic Waste Disposal Services Market Growth (Status and Outlook) 2025-2031

According to this study, the global Peptide CRO Services market size will reach US$ 900 million by 2031.

Peptide CRO services refer to integrated outsourced R&D services provided by professional third-party R&D institutions around peptide drugs or functional peptide products, covering the entire process of peptide sequence design, solid phase synthesis, liquid phase purification, structure identification, modification (such as PEGylation, cyclization), impurity research, formulation development and CMC registration support. With the widespread application of peptide drugs in the fields of tumors, metabolic diseases, vaccine adjuvants, etc., customers' demand for process development and pilot-scale expansion of high-purity, long-acting, and difficult-to-synthesize peptides continues to grow, which has promoted the rapid development of the peptide CRO service market. This type of service has the characteristics of high professional barriers, strong entry barriers, and strict equipment and compliance requirements. It is widely used in global new drug development and generic drug consistency evaluation projects.

United States market for Peptide CRO Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Peptide CRO Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Peptide CRO Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Peptide CRO Services players cover Bachem AG, CPC Scientific, CSBio, Peptide Institute, AmbioPharm, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Peptide CRO Services Industry Forecast” looks at past sales and reviews total world Peptide CRO Services sales in 2024, providing a comprehensive analysis by region and market sector of projected Peptide CRO Services sales for 2025 through 2031. With Peptide CRO Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peptide CRO Services industry.

This Insight Report provides a comprehensive analysis of the global Peptide CRO Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Peptide CRO Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Peptide CRO Services market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peptide CRO Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peptide CRO Services.

This report presents a comprehensive overview, market shares, and growth opportunities of Peptide CRO Services market by product type, application, key players and key regions and countries.

Segmentation by Type:
Linear Peptide Synthesis
Cyclic Peptide Synthesis
Modified Peptide Synthesis
Others

Segmentation by Application:
Pharmaceutical Companies
Biological Laboratories
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bachem AG
CPC Scientific
CSBio
Peptide Institute
AmbioPharm
PeptiSystems
ABZENA PLC
Buchi
Aurigene Pharmaceutical Services
Syngene
Cusabio
Immunocure
Thermo Fisher
Svar Life Science
PolyPeptide
JYMed Technology
Peptites Biotech
Sun-Novo Pharmaceutical Research
Genevoyager
GenScript
Viva Biotech
Space Peptides Pharmaceutical
TriApex Laboratories
Go Top Peptide Biotech
IMED Bioscience
Motif Biotechnology

Please note: The report will take approximately 2 business days to prepare and deliver. Show more